We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.53B
AUM Growth
+$93.1M
(+1.1%)
Cap. Flow
+$472M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
812
New
193
Increased
197
Reduced
149
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$188M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
Electronic Arts
EA
|
+$112M |
| 4 |
Autodesk
ADSK
|
+$97.3M |
| 5 |
Keysight
KEYS
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$123M |
| 2 |
Amphenol
APH
|
+$113M |
| 3 |
Cencora
COR
|
+$108M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
HP
HPQ
|
+$91.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.52% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESTE
51
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $37.9M | 0.44% |
1,872,093
+86,494
| +5% | +$1.51M |
|
52
Expedia Group
EXPE
$37.3B
| $37.6M | 0.44% |
364,754
-159,260
| -30% | -$17.6M |
|
53
Krystal Biotech
KRYS
$9.69B
| $37.3M | 0.44% |
321,944
+277,721
| +628% | +$33.9M |
|
54
Immunovant
IMVT
$8.12B
| $37M | 0.43% |
964,083
+328,992
| +52% | +$7.44M |
|
55
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
| $35.9M | 0.42% |
854,824
+399,251
| +88% | +$17.8M |
|
56
Vera Therapeutics
VERA
$2.14B
| $35.1M | 0.41% |
2,562,600
+808,910
| +46% | +$13.9M |
|
57
CrowdStrike
CRWD
$215B
| $35M | 0.41% |
+835,480
| New | +$32.5M |
|
|
SBOW
58
DELISTED
SilverBow Resources, Inc.
SBOW
| $34.8M | 0.41% |
+971,786
| New | +$35.4M |
|
|
CPE
59
DELISTED
Callon Petroleum Company
CPE
| $34.6M | 0.41% |
885,476
-13,524
| -2% | -$500K |
|
|
NEWR
60
DELISTED
New Relic, Inc.
NEWR
| $34.4M | 0.4% |
402,000
+376,203
| +1,458% | +$30.3M |
|
61
Neurocrine Biosciences
NBIX
$16.9B
| $34.1M | 0.4% |
303,085
-849,104
| -74% | -$89.4M |
|
62
Henry Schein
HSIC
$10.2B
| $33.8M | 0.4% |
454,647
+254,706
| +127% | +$19.6M |
|
63
NVIDIA
NVDA
$5.14T
| $33.6M | 0.39% |
772,320
+649,200
| +527% | +$29.1M |
|
64
Alkermes
ALKS
$8.31B
| $32.8M | 0.38% |
+1,170,689
| New | +$34.3M |
|
65
On Holding
ONON
$12.6B
| $31.7M | 0.37% |
1,138,479
+407,341
| +56% | +$12.9M |
|
66
Axsome Therapeutics
AXSM
$10.9B
| $31.6M | 0.37% |
452,107
+12,182
| +3% | +$911K |
|
|
NATI
67
DELISTED
National Instruments Corp
NATI
| $31.2M | 0.37% |
+522,600
| New | +$30.7M |
|
68
Ovintiv
OVV
$16.8B
| $31M | 0.36% |
+651,173
| New | +$29.5M |
|
69
Skyworks Solutions
SWKS
$10.1B
| $31M | 0.36% |
+314,143
| New | +$33.4M |
|
|
ANSS
70
DELISTED
Ansys
ANSS
| $30.3M | 0.36% |
+101,906
| New | +$32.3M |
|
|
BPMC
71
DELISTED
Blueprint Medicines
BPMC
| $30.2M | 0.35% |
602,027
+310,665
| +107% | +$16.6M |
|
72
US Foods
USFD
$21.8B
| $30.1M | 0.35% |
757,901
+92,681
| +14% | +$3.84M |
|
73
Capri Holdings
CPRI
$1.89B
| $29.9M | 0.35% |
567,808
+511,126
| +902% | +$23.2M |
|
74
Vontier
VNT
$4.78B
| $29.7M | 0.35% |
961,959
+30,842
| +3% | +$950K |
|
75
BridgeBio Pharma
BBIO
$16B
| $29.7M | 0.35% |
1,125,634
+835,634
| +288% | +$23.7M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Woodline Partners held 812 positions worth $8.53B, up 1.1% from $8.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $472M of net new capital in Q3 2023, opening 193 new positions and adding to 197 existing holdings. Its largest new stake was Analog Devices: 1,016,972 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Hess, an estimated $123M trimmed.
- Woodline Partners's largest Q3 2023 buy was Analog Devices: 1,016,972 shares worth $178M.
- Woodline Partners added most to AbbVie in Q3 2023, an estimated $121M increase.
- Woodline Partners's biggest Q3 2023 reduction was Hess, cutting an estimated $123M.
- Woodline Partners fully exited HP in Q3 2023, selling an estimated $91.2M.
- Woodline Partners's ten largest holdings make up 17% of its $8.53B portfolio in Q3 2023.
- Woodline Partners opened 193 new positions and closed 231 in Q3 2023.
- Woodline Partners's portfolio value rose 1.1% quarter-over-quarter to $8.53B.
Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.